Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Przegl Lek ; 72(9): 482-4, 2015.
Artículo en Polaco | MEDLINE | ID: mdl-26827573

RESUMEN

Carbon monoxide poisoning is one of the most frequent types of poisoning caused by gases. Exposure of a pregnant woman to carbon monoxide is connected with transmission of this gas to her fetus what may cause oxygen deficiency, and further, the damage to its organs. The article describes a case of carbon monoxide poisoning of a 28-weeks pregnant woman who was treated in a hyperbaric chamber. Therapy was successful and the woman gave birth to a healthy, full term infant. In case of poisoning to a pregnant woman the above seems to be the most advantageous solution.


Asunto(s)
Intoxicación por Monóxido de Carbono/terapia , Oxigenoterapia Hiperbárica , Adulto , Femenino , Humanos , Recién Nacido , Parto , Embarazo
2.
Vaccines (Basel) ; 11(8)2023 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-37631849

RESUMEN

Preterm newborns are babies born before the end of the 36th week of gestational life. They are at increased risk of infection and death from infectious diseases. This is due, among other things, to the immaturity of the immune system and the long hospitalisation period. One common infectious disease in the paediatric population is rotavirus (RV) infection. We now have specific vaccines against this pathogen. The aim of this study was to evaluate the safety of rotavirus vaccination in the neonatal intensive care unit (NICU) setting and to determine the tolerance of this vaccine in low- and extremely low-weight children. The study carried out at a single centre, the University Hospital in Kraków, also allowed the assessment of vaccination trends during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. During the observation period, 126 premature newborns received the RV vaccine. We observed no adverse effects, and our analysis shows safety and good tolerance of the vaccine among preterm babies. In addition, we observed an increase in vaccination rates between 2019 and 2021, partly explained by parents' anxiety about infectious diseases in the era of pandemics and partly explained by a change in vaccination policy in Poland and the introduction of refunding for RV vaccination.

3.
Nutrients ; 12(10)2020 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-33066338

RESUMEN

The gut microbiota plays a pivotal role in the maintenance of human health. Numerous factors, including the mode of delivery, impact early gut colonization in newborns. Recent research focuses on the use of probiotics in the prevention of gut dysbiosis in newborns delivered by cesarean section (CS). The objective of this study was to determine whether a probiotic supplement given to newborns delivered by CS during their stay in the maternity ward alters the pattern of early gut colonization by lactic acid bacteria versus potential pathogens. A prospective, randomized trial was conducted. In total, 150 newborns, born at 38-40 weeks gestational age and delivered by CS, were included in the study. They were randomized into the intervention group, supplemented orally with a probiotic containing Bifidobacterium breve PB04 and Lactobacillus rhamnosus KL53A, and the control group. Stool samples were obtained on days 5 and 6 of life and after one month of life and were analyzed for the presence and abundance of the main groups of bacteria. An application of two probiotic bacteria during the first days of life after CS resulted in quick and abundant colonization by days 5 and 6, with high populations of L. rhamnosus and B. breve. The applied bacterial strains were present in the majority of neonates one month after. The supplementation of term neonates delivered by cesarean section immediately after birth with a mixture of L. rhamnosus and B. breve enriched the gut microbiota composition with lactic acid bacteria.


Asunto(s)
Bifidobacterium breve , Cesárea , Suplementos Dietéticos , Disbiosis/prevención & control , Microbioma Gastrointestinal , Fenómenos Fisiológicos Nutricionales del Lactante/fisiología , Recién Nacido/fisiología , Lacticaseibacillus rhamnosus , Probióticos/administración & dosificación , Disbiosis/microbiología , Humanos , Estudios Prospectivos , Factores de Tiempo
4.
Pediatr Infect Dis J ; 35(9): 967-71, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27254035

RESUMEN

BACKGROUND: Previously, we found that plasma protein C (PC) activity ≤10% significantly increased the probability of the occurrence of death during neonatal sepsis. Accordingly, if the activity of plasma PC declined during the course of sepsis to ≤10%, we administered a nonactivated PC zymogen to increase a PC activity. The aim of that retrospective analysis was to explore treatment effects of PC zymogen supplementation in septic infants, with plasma PC activity ≤10%. METHODS: A database was used to locate 85 newborns treated with PC from among 458 analyzed infants with confirmed sepsis. RESULTS: The median birth weight and gestational age of treated infants were, respectively, 1010.0 g and 29 weeks. In 47 infants, early-onset sepsis developed, whereas in 38 neonates, late-onset sepsis was recognized. PC was given as a single dose of 200 IU/kg. Among 458 septic patients, death occurred in 19 newborns (4.2%), exclusively in infants with plasma PC activity ≤10%. In 15 infants, death occurred in the course of early-onset sepsis and 4 newborns died of late-onset sepsis (early-onset sepsis vs. late-onset sepsis; P = 0.036; χ with the Yates correction). CONCLUSIONS: An increased risk of death in septic neonates with plasma PC activity ≤10% suggests the necessity for its evaluation and possibility of supplementation of PC zymogen.


Asunto(s)
Enfermedades del Recién Nacido/tratamiento farmacológico , Enfermedades del Recién Nacido/mortalidad , Sepsis Neonatal/tratamiento farmacológico , Sepsis Neonatal/mortalidad , Proteína C/uso terapéutico , Femenino , Humanos , Recién Nacido , Masculino , Sepsis Neonatal/sangre , Sepsis Neonatal/epidemiología , Proteína C/análisis , Proteína C/metabolismo , Estudios Retrospectivos , Resultado del Tratamiento
5.
Med Wieku Rozwoj ; 16(3): 205-11, 2012.
Artículo en Polaco | MEDLINE | ID: mdl-23378398

RESUMEN

BACKGROUND: Feeding intolerance frequently occurs during the first several weeks of life in very low birth weight infants and may require the reduction of oral feeding. When significantly expressed, it may lead to the development of necrotizing enterocolitis. Apart from breast milk, also the maintenance of normal peristalsis, enterocyte nourishment and keeping a low pH value in the stomach seem to be important points in the NEC prophylaxis. AIM: The authors present the results of the randomized pilot study, performed in two, differently fed groups of VLBW newborns. The aim of the study was to compare the frequency of feeding intolerance, necrotizing enterocolitis, sepsis caused by Gram negative bacteria, intestinal perforation and the number of deaths between the study group and the control group of newborns. MATERIALS AND METHODS: 106 VLBW newborns were qualified for research. In the study group (50 newborns), apart from the mother's milk or preterm formula, infants were enteraly receiving a glutamine/ amino acid solution, the osmolality of which was comparable to amniotic fluid. The pH value of the solution was 5.5 so as to lower acidity of the stomach fluids. In the control group (56 newborns) infants were fed enteraly exclusively with the mother's milk or preterm formula. The patients in the two groups were comparable with regard to birth weight, gestational age, Apgar score and CRIB score, and the frequency of antenatal corticosteroid administration. RESULTS: There was a significantly lower risk of feeding intolerance in infants who were receiving the glutamine/amino acid solution (p=0.015). Also there was a lower risk of NEC (5 vs 10 cases), intestinal perforation (1 vs 4 cases), sepsis caused by Gram negative bacteria (1 vs 4 cases) and death (1 vs 3) in the study group. However, none of these differences reached statistical significance. CONCLUSIONS: Enteral supplementation of glutamine/amino acid solution given simultaneously with enteral feeding is safe and may significantly reduce feeding intolerance in very low birth weight infants in their first days or weeks of life. The results of our research can be useful when attempting to work out the principles of NEC prophylaxis by means of maintaining normal peristalsis, enterocyte nourishment and keeping a low pH value in the stomach.


Asunto(s)
Nutrición Enteral , Trastornos de Ingestión y Alimentación en la Niñez/prevención & control , Glutamina/administración & dosificación , Fórmulas Infantiles/administración & dosificación , Recién Nacido de muy Bajo Peso , Leche Humana , Humanos , Recién Nacido , Proyectos Piloto , Estudios Prospectivos
6.
Med Wieku Rozwoj ; 13(1): 40-4, 2009.
Artículo en Polaco | MEDLINE | ID: mdl-19648658

RESUMEN

Bacillus cereus is an aerobic or facultative anaerobic Gram-positive rod which is ubiquitous in the environment. The incidence of neonatal infections is very low. The clinical course is serious, usually life- threatening or permanently damaging the central nervous system. The immature immune system, subjected to invasive procedures, increases the morbidity risk in this age group, especially in extremely low birth weight infants. Diagnostic difficulties and insusceptibility to ''first- line'' antibiotics can delay effective therapy and increase the risk of its failure. We report a 730 g preterm neonate, delivered at 27 weeks gestation with late- onset sepsis due to Bacillus cereus. The disease course was complicated by development of brain abscesses. We describe the clinical course of infection, diagnostic difficulties and the treatment. After the 140 days of hospitalization and relatively long period of therapy with different antibiotics, the patient was discharged from hospital in good condition. Despite of transmission of infection to the central nervous system, the introduced therapy prevented severe neurological disabilities as confirmed during the evaluation according to the Bayley Scale of Infant Development, performed at 29 months of life.


Asunto(s)
Bacillus cereus/aislamiento & purificación , Absceso Encefálico/microbiología , Recien Nacido con Peso al Nacer Extremadamente Bajo , Enfermedades del Prematuro/diagnóstico , Enfermedades del Prematuro/microbiología , Sepsis/diagnóstico , Sepsis/microbiología , Antibacterianos/uso terapéutico , Absceso Encefálico/diagnóstico , Absceso Encefálico/tratamiento farmacológico , Femenino , Humanos , Recién Nacido , Enfermedades del Prematuro/tratamiento farmacológico , Sepsis/tratamiento farmacológico
7.
Eur J Pediatr ; 165(9): 585-9, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16636814

RESUMEN

OBJECTIVE: The aim of this prospective, observational study was to establish the prognostic values of plasma antithrombin III (ATIII) and protein C (PC) functional levels, determined in 150 neonates with suspected late-onset sepsis. OBSERVATIONS: Both the ATIII and PC concentrations were significantly lower in neonates with sepsis, either confirmed or not confirmed by blood culture, than data obtained in infants with excluded disease. The lowest values of plasma ATIII and PC were observed in neonates who had died in the course of sepsis. The differences between survivors and non-survivors were statistically significant (respectively, for ATIII P=0.003 and for PC P=0.00002). A highly statistically significant correlation (P=0.0016) between plasma PC functional level and risk of death was found in patients with sepsis. However, plasma ATIII concentration, evaluated in the same group of patients, did not correlate with the occurrence of death. CONCLUSION: We concluded that the measurement of plasma ATIII and, especially, PC levels may facilitate the recognition of sepsis and, with respect to PC, may have a prognostic value. Plasma PC functional concentration below 10% might be the indication for supplementation of PC concentrate.


Asunto(s)
Antitrombina III/metabolismo , Bacteriemia/sangre , Bacteriemia/diagnóstico , Proteína C/metabolismo , Análisis de Varianza , Bacteriemia/microbiología , Bacteriemia/mortalidad , Biomarcadores/sangre , Estudios de Casos y Controles , Diagnóstico Precoz , Infecciones por Bacterias Gramnegativas/sangre , Infecciones por Bacterias Gramnegativas/diagnóstico , Infecciones por Bacterias Grampositivas/sangre , Infecciones por Bacterias Grampositivas/diagnóstico , Humanos , Lactante , Recién Nacido , Polonia/epidemiología , Estudios Prospectivos , Factores de Riesgo , Análisis de Supervivencia , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA